BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells (Q44834824)
Jump to navigation
Jump to search
scientific article published on 11 December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells |
scientific article published on 11 December 2003 |
Statements
1 reference
BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells (English)
1 reference
Su Chu
1 reference
Melissa Holtz
1 reference
Mamta Gupta
1 reference
Ravi Bhatia
1 reference
11 December 2003
1 reference
Identifiers
1 reference